⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0002111813

Parikh Anand Kiran

Reports to the SEC for 1 company · AUSTIN, TX

Transactions

15

Companies

1

Filings

5

CIK

0002111813

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-21	FTHFaeth Therapeutics, Inc. · Performance-Based Stock Option (right to buy)A Award	Director, President and CEO	AAward	+398K sh	—	—	398,018
2026-06-22	FTHFaeth Therapeutics, Inc.P Purchase	Director, President and CEO	PPurchase	+2,806 sh	$19.76	+$55.4K	764,234
2026-06-22	FTHFaeth Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+45.3K sh	$1.16	+$52.5K	809,486
2026-06-22	FTHFaeth Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+8,213 sh	$1.16	+$9,527.08	817,699
2026-06-22	FTHFaeth Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−45.3K sh	—	—	91,632
2026-06-22	FTHFaeth Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−8,213 sh	—	—	4,107
2026-06-15	FTHFaeth Therapeutics, Inc.C Conversion	Director, President and CEO	CConversion	+761K sh	—	—	761,428
2026-06-15	FTHFaeth Therapeutics, Inc. · Series B Preferred StockC Conversion	Director, President and CEO	CConversion	−761.428 sh	—	—	0
2026-02-19	FTHFaeth Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+1.24M sh	—	—	1,239,305
2026-02-17	FTHFaeth Therapeutics, Inc. · Series B Preferred StockA Award	Director, President and CEO	AAward	+761.428 sh	—	—	761,428
2026-02-17	FTHFaeth Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+12.3K sh	—	—	12,320
2026-02-17	FTHFaeth Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+137K sh	—	—	136,884
2026-02-17	FTHFaeth Therapeutics, Inc. · Series B Preferred StockA Award	Director, President and CEO	AAward	+810K sh	—	—	809,822
2026-02-17	FTHFaeth Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+92.5K sh	—	—	92,533
2026-02-17	FTHFaeth Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+56.7K sh	—	—	56,673

Recent filings

5

Accepted (ET)
Jul 234
Parikh Anand Kiran0002111813-26-000012
SEC(opens sec.gov)
Jun 244
Parikh Anand Kiran0002111813-26-000010
SEC(opens sec.gov)
Jun 164/A
Parikh Anand Kiran0002111813-26-000008
SEC(opens sec.gov)
Jun 164
Parikh Anand Kiran0002111813-26-000009
SEC(opens sec.gov)
Feb 194
Parikh Anand Kiran0002111813-26-000004
SEC(opens sec.gov)

Companies

1

Faeth Therapeutics, Inc.Director, President and CEOFTH

Address

C/O FAETH THERAPEUTICS, INC. 701 TILLERY STREET #12 #1010

AUSTIN, TX, 78702